Are the new reagents really more sensitive? [3]

American Journal of Clinical Pathology

Volumn 113, Issue 5, 2000, Pages 742-743

  Sanfelippo, M J ^a   McMahon, E J ^a  

^a Medical Science Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; REAGENT; THROMBOPLASTIN;

BIOMEDICAL TECHNOLOGY ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HEMOPHILIA B; HEMOSTASIS; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SAMPLING;

HUMANS; INDICATORS AND REAGENTS; PARTIAL THROMBOPLASTIN TIME; SENSITIVITY AND SPECIFICITY;

EID: 0034425143     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. The clinical impact of increased sensitivity PT and aPTT coagulation assays